Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reuss

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Oncotarget|April 7, 2016
Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitisPhilipp Seidel, Martina Remus, Michael Delacher, et al.
JAMIA Open|November 7, 2024
Targetable molecular algorithm and training platform development for the treatment of non-small cell lung cancerKrithika Bhuvaneshwar, Chul Kim, Kaushal Parikh, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
Mutations in Mlph, encoding a member of the Rab effector family, cause the melanosome transport defects observed in leaden miceL E Matesic, R Yip, A E Reuss, et al.
JAMA Network Open|December 1, 2020
Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti-PD1/PDL1 Clinical TrialsJoshua E Reuss, Diana Stern, Jared C Foster, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2023
High levels of expression of Trop-2 in thymic epithelial tumorsVincent Yeung, Jacob Zaemes, Justin Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Early 3+3 Trial Dose-Escalation Phase I Clinical Trial Design and Suitability for Immune Checkpoint InhibitorsOsama E Rahma, Joshua E Reuss, Anita Giobbie-Hurder, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
JTO Clinical and Research Reports|December 6, 2022
Remarkable Intracranial Response to Sotorasib in a Patient With <i>KRAS</i> <sup>G12C</sup>-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case ReportJustin Yeh, Jennifer A Marks, Ali H Alzeer, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and managementJarushka Naidoo, Joshua E Reuss, Karthik Suresh, et al.
Arthritis and Rheumatism|May 16, 2001
IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patientsW Kaluza, M Leirisalo-Repo, E Märker-Hermann, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Oncotarget|April 7, 2016
Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitisPhilipp Seidel, Martina Remus, Michael Delacher, et al.
JAMIA Open|November 7, 2024
Targetable molecular algorithm and training platform development for the treatment of non-small cell lung cancerKrithika Bhuvaneshwar, Chul Kim, Kaushal Parikh, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
Mutations in Mlph, encoding a member of the Rab effector family, cause the melanosome transport defects observed in leaden miceL E Matesic, R Yip, A E Reuss, et al.
JAMA Network Open|December 1, 2020
Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti-PD1/PDL1 Clinical TrialsJoshua E Reuss, Diana Stern, Jared C Foster, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2023
High levels of expression of Trop-2 in thymic epithelial tumorsVincent Yeung, Jacob Zaemes, Justin Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Early 3+3 Trial Dose-Escalation Phase I Clinical Trial Design and Suitability for Immune Checkpoint InhibitorsOsama E Rahma, Joshua E Reuss, Anita Giobbie-Hurder, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
JTO Clinical and Research Reports|December 6, 2022
Remarkable Intracranial Response to Sotorasib in a Patient With <i>KRAS</i> <sup>G12C</sup>-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case ReportJustin Yeh, Jennifer A Marks, Ali H Alzeer, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and managementJarushka Naidoo, Joshua E Reuss, Karthik Suresh, et al.
Arthritis and Rheumatism|May 16, 2001
IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patientsW Kaluza, M Leirisalo-Repo, E Märker-Hermann, et al.
Pageof 14